2-amino-3-(methylsulfanyl)propanoic acid, 95.0%, 5g

3,3-DIMETHYL-1H-PYRROLO[3,2-B]PYRIDIN-2(3H)-ONE, 95.0%, 2g

4-Chloro-6-(4-fluorophenyl)thieno[3,2-d]pyrimidine, 92.0%, 5g

2-(2-formyl-4-methoxyphenoxy)acetonitrile, 95%, 5g

N-[2-[[4-[4-(3-Bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]sulfamide, 95%, 100mg

(2-N-Boc-Aminothiazol-4-yl)methanol, 98.0%, 5g

(4S,4aS,8aR)-4-phenyldecahydro-4-quinolinol ethanedioate (salt), 95.0%, 1g

(1S,2R)-METHYL 2-(2-HYDROXYETHYL)CYCLOPROPANECARBOXYLATE, 95.0%, 250mg

3-Bromo-5-chloronitrobenzene, 95.0%, 1g

tert-Butyl 3-(hydroxymethyl)-3-methylazetidine-1-carboxylate, 95.0%, 1g

5-Trityl-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one, 95.0%, 5g

5-Amino-2-methylphenol, 95.0%, 500g

Recipiente de cristalización ROTILABO® con pico, 20 ml, 40 mm, 10 Unidad(es)